study	group	count	intervention	measurement_type	substance	tissue	method	label	time	time_unit	mean	median	min	max	sd	se	cv	unit	comments
Shin2020	GG/CC	13.0	LOS50	cumulative amount	losartan+exp3174	urine	HPLC/FS	losartan_exp3174_urine_GG_CC	0.0	hr	0.0	NA	NA	NA	NA	NA	NA	µmol	NA
Shin2020	GG/CC	13.0	LOS50	cumulative amount	losartan+exp3174	urine	HPLC/FS	losartan_exp3174_urine_GG_CC	4.0	hr	3.54	NA	NA	NA	1.88	NA	NA	µmol	NA
Shin2020	GG/CC	13.0	LOS50	cumulative amount	losartan+exp3174	urine	HPLC/FS	losartan_exp3174_urine_GG_CC	8.0	hr	4.24	NA	NA	NA	1.06	NA	NA	µmol	NA
Shin2020	GT/CT	12.0	LOS50	cumulative amount	losartan+exp3174	urine	HPLC/FS	losartan_exp3174_urine_GT_CT	0.0	hr	0.0	NA	NA	NA	NA	NA	NA	µmol	NA
Shin2020	GT/CT	12.0	LOS50	cumulative amount	losartan+exp3174	urine	HPLC/FS	losartan_exp3174_urine_GT_CT	4.0	hr	4.55	NA	NA	NA	4.07	NA	NA	µmol	NA
Shin2020	GT/CT	12.0	LOS50	cumulative amount	losartan+exp3174	urine	HPLC/FS	losartan_exp3174_urine_GT_CT	8.0	hr	4.15	NA	NA	NA	2.03	NA	NA	µmol	NA
Shin2020	TT/TT	13.0	LOS50	cumulative amount	losartan+exp3174	urine	HPLC/FS	losartan_exp3174_urine_TT_TT	0.0	hr	0.0	NA	NA	NA	NA	NA	NA	µmol	NA
Shin2020	TT/TT	13.0	LOS50	cumulative amount	losartan+exp3174	urine	HPLC/FS	losartan_exp3174_urine_TT_TT	4.0	hr	5.67	NA	NA	NA	1.87	NA	NA	µmol	NA
Shin2020	TT/TT	13.0	LOS50	cumulative amount	losartan+exp3174	urine	HPLC/FS	losartan_exp3174_urine_TT_TT	8.0	hr	3.98	NA	NA	NA	1.11	NA	NA	µmol	NA
